Table 1.
Characteristics of 207 hyperthyroid patients treated with 131I
| Patients characteristics | Number of cases | Percentage/Mean ± SD |
|---|---|---|
| Gender | ||
| Male | 78 | (37.7%) |
| Female | 129 | (62.3%) |
| Age: (years) | 207 | 38.79 ± 11.99 |
| Family History | ||
| Present | 30 | (14.5%) |
| Absent | 177 | (85.5%) |
| Medical treatment | ||
| Yes | 198 | (95.7%) |
| No | 9 | (4.3%) |
| GO* | ||
| Present | 15 | (7.2%) |
| Absent | 192 | (92.8%) |
| Previous surgery | ||
| Present | 40 | (19.3%) |
| Absent | 167 | (80.7%) |
| Baseline Thyroid uptake (%) | 207 | 18.6 ± 11.2% |
| Dose of 131I (mean ± SD) | 207 | 488.4 ± 129.5 MBq (13.2 ± 3.5 mCi) |
*
GO: Graves’ ophthalmopathy.